• Spleen-Targeted mRNA Vaccines Drive ISG15+ CD8+ T Cell Immun

  2026-05-15

  Lin et al. present a spleen-targeted neoantigen mRNA vaccine (STNvac) that induces potent antitumor immunity in hepatocellular carcinoma (HCC) by activating ISG15+ CD8+ T cells and promoting tertiary lymphoid structure (TLS) formation. This mechanistic advance highlights organ-targeted mRNA delivery and distinct T cell subtypes as pivotal for overcoming immune resistance in solid tumors.

• HYPK Enables Efficient NatA-Mediated N-Terminal Acetylation

  2026-05-14

  Lentzsch et al. (2025) reveal that HYPK acts as a ribosome exchange factor for N-terminal acetyltransferase A (NatA), overcoming previous paradoxes in NatA regulation. This mechanism allows sub-stoichiometric NatA to globally acetylate the nascent proteome, reshaping understanding of cotranslational protein modification.

• Optimizing ARCA Capped mRNA Synthesis with HyperScribe Kit

  2026-05-14

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus empowers researchers to produce high-yield, translation-ready ARCA-capped mRNA tailored for advanced applications, including mRNA vaccine development and RNAi experiments. This guide details experimental workflows, scenario-driven optimizations, and troubleshooting strategies for reproducible, high-quality results.

• HotStart Universal 2X Green qPCR Master Mix: Specificity and

  2026-05-13

  HotStart Universal 2X Green qPCR Master Mix enables precise gene expression quantification by combining hot-start Taq polymerase with robust dye-based detection. The K1170 kit from APExBIO minimizes non-specific amplification, ensuring high specificity and reproducibility in real-time PCR gene expression analysis.

• Deep Learning Enhances Cardiotoxicity Screening in iPSC-CMs

  2026-05-13

  This study introduces a deep learning-based high-content screening platform employing iPSC-derived cardiomyocytes to detect drug-induced cardiotoxicity early in drug discovery. The approach accurately identifies diverse cardiotoxic liabilities and chemical scaffolds, offering a scalable, human-relevant solution to de-risk pharmaceutical pipelines.

• Bile Acid Metabolism Subtypes Predict Immune Dysfunction in

  2026-05-12

  Feng et al. introduce a molecular subtyping approach for colorectal cancer (CRC) based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as key biomarkers of immune dysfunction and prognosis. This integrative strategy refines our understanding of the tumor immune microenvironment (TIME) in CRC and provides a foundation for improved patient stratification and biomarker-driven research.

• Substance P: Advanced Protocols for Pain and Immune Research

  2026-05-12

  Substance P from APExBIO empowers researchers with a high-purity tachykinin neuropeptide for dissecting pain, inflammation, and immune pathways. This guide demystifies experimental workflows, embraces spectral analytics, and delivers actionable troubleshooting insights rooted in the latest reference innovations.

• Reactive Oxygen Species Assay Kit: Precision in Live Cell RO

  2026-05-11

  The APExBIO Reactive Oxygen Species Assay Kit leverages the DCFH-DA fluorescent probe for highly sensitive, quantitative ROS measurement in live cells. This workflow-driven guide details optimized protocols, advanced troubleshooting, and practical insights for oxidative stress and apoptosis research, translating the latest findings on redox signaling into reproducible laboratory results.

• Solving Lab Challenges with HyperScript™ First-Strand cDNA S

  2026-05-11

  This article offers scenario-driven guidance for scientists using the HyperScript™ First-Strand cDNA Synthesis Kit (SKU K1072). Drawing on real-world experimental needs, it demonstrates how this kit enhances reproducibility, sensitivity, and workflow efficiency in gene expression studies, especially for low-abundance transcripts or complex RNA templates.

• Calpain Inhibitor I, ALLN: Technical Guide for Apoptosis & I

  2026-05-10

  Calpain Inhibitor I, ALLN, is a potent, selective inhibitor for calpain and cathepsin proteases, essential for apoptosis assays and ischemia-reperfusion injury models where precise control of cysteine protease activity is required. It is suitable for research workflows demanding minimal off-target cytotoxicity and robust inhibition of calpain/cathepsin activity but should not be used in diagnostic or medical applications.

• T7 RNA Polymerase: Unraveling Tumor Barriers with In Vitro R

  2026-05-09

  Explore the scientific foundation and translational impact of T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, in advanced RNA synthesis for tumor microenvironment research and immunotherapy. This article uniquely connects enzyme selection with breakthroughs in RNA-based modulation of cancer barriers.

• T7 RNA Polymerase in mRNA Vaccine Engineering: Mechanistic A

  2026-05-08

  Explore how T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, is revolutionizing mRNA vaccine development and advanced RNA research. This in-depth article uniquely bridges mechanistic insight with actionable protocol guidance, setting it apart from existing resources.

• Wortmannin: Precision PI3K Inhibition in Cancer and Virology

  2026-05-08

  Wortmannin stands out as a potent, selective, and irreversible PI3K inhibitor, enabling researchers to dissect PI3K/Akt/mTOR pathways with unmatched fidelity. By leveraging its dual kinase inhibition and documented efficacy in both cancer and antiviral models, Wortmannin from APExBIO empowers scientists to refine experimental design, troubleshoot workflow bottlenecks, and expand translational findings across cell signaling landscapes.

• Genetically Encoded NADH/NAD+ Redox Biosensor in E. coli

  2026-05-07

  This study introduces a genetically encoded ratiometric biosensor leveraging the Rex transcription factor to enable noninvasive, high-throughput measurement of NADH/NAD+ redox states in bacteria. The biosensor advances metabolic research by facilitating precise and scalable redox profiling, essential for understanding bacterial physiology and optimizing metabolic engineering strategies.

• Polyethylenimine Linear (PEI), MW 40,000: Next-Gen Transfect

  2026-05-07

  Explore how Polyethylenimine Linear (PEI), MW 40,000 accelerates functional genomics and recombinant protein production. This article reveals advanced assay strategies and protocol nuances for maximizing transfection performance, offering a unique perspective compared to existing resources.

615 records 8/41 page Previous Next First page 上5页 678910 下5页 Last page